Commentary on: Downes, S. (2004) Resource Profiles

Autor: David Wiley

Publikováno v: Journal of Interactive Media in Education, Vol 2004, Iss 1 (2004)

Abstract: In this response to Downes' very substantial article I can touch on only a few points. I have chosen to pass over the technical comments which might be made (e.g., concerns about reliability and availability with the proposed system of dist

Externí odkaz: https://doaj.org/article/db7152f1a86d4802af2ac8d524b740c6

Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria.

Autor: Jensen I; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany., Heine J; Department of Neurology, Hannover Medical School, Hanover, Germany., Ruf VC; Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany., Compta Y; Movement Disorders Unit, Neurology Service, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Catalonia, Spain., Porcel LM; Neurology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain., Troakes C; Basic and Clinical Neuroscience Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Vamanu A; Basic and Clinical Neuroscience Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Downes S; Basic and Clinical Neuroscience Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Irwin D; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Cohen J; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Lee EB; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Institute on Aging, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Nilsson C; Department of Clinical Sciences, Division of Neurology, Lund University, Lund, Sweden., Englund E; Department of Clinical Sciences, Division of Pathology instead of Neurology, Lund University, Lund, Sweden., Nemati M; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany., Katzdobler S; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany., Levin J; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Strasse 17, Munich, Germany., Pantelyat A; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Seemiller J; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Berger S; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., van Swieten J; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands., Dopper E; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands., Rozenmuller A; Department of Pathology, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, The Netherlands., Kovacs GG; Laboratory Medicine Program and Krembil Brain Institute, University Health Network, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology and Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada., Bendahan N; Edmond J. Safra Program in Parkinson's Disease and the Rossy Progressive Supranuclear Palsy Centre, Division of Neurology, Toronto Western Hospital, University Health Network and the University of Toronto, Toronto, Ontario, Canada., Lang AE; Edmond J. Safra Program in Parkinson's Disease and the Rossy Progressive Supranuclear Palsy Centre, Division of Neurology, Toronto Western Hospital, University Health Network and the University of Toronto, Toronto, Ontario, Canada., Herms J; Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Strasse 17, Munich, Germany., Höglinger G; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Strasse 17, Munich, Germany., Hopfner F; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.

Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Sep; Vol. 39 (9), pp. 1514-1522. Date of Electronic Publication: 2024 Jun 07.

Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.

Autor: Liu J; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., He Y; Fermentation Facility, Biochemistry and Biophysics Center, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA., Lwin C; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Han M; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Guan B; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Naik A; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Bender C; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Moore N; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Huryn LA; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Sergeev YV; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Qian H; Visual Function Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Zeng Y; Visual Function Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Dong L; Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Liu P; Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Lei J; Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Haugen CJ; Genetic Engineering Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA., Prasov L; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105, USA.; Department of Human Genetics, University of Michigan, Ann Arbor, MI 48105, USA., Shi R; Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 100730 Beijing, China., Dollfus H; Centre de référence pour les Affections Rares Ophtalmologiques CARGO, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, UMRS_1112, Strasbourg 67091, France., Aristodemou P; Cyprus Institute of Neurology and Genetics, Nicosia 1683, Cyprus.; VRMCy Centre, Limassol 3025, Cyprus., Laich Y; UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.; Department of Genetics, Moorfields Eye Hospital NHS Trust, London EC1V 2PD, UK., Németh AH; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, ACE Building, Nuffield Orthopaedic Centre, Oxford OX3 7HE, UK.; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK., Taylor J; Oxford Regional Genetics Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK., Downes S; Nuffield Department of Ophthalmology, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford OX3 9DU, UK.; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK., Krawczynski MR; Department of Medical Genetics, Poznan University of Medical Sciences, Poznan 60-512, Poland., Meunier I; National Referent Centre for Rare Sensory Diseases, Montpellier University Hospital, Montpellier University, Montpellier 34295, France., Strassberg M; Invitae Corporation, San Francisco, CA 94103, USA., Tenney J; Division of Medical Genetics, Department of Pediatrics, UCSF School of Medicine, San Francisco, CA 94143, USA., Gao J; Division of Medical Genetics, Department of Pediatrics, UCSF School of Medicine, San Francisco, CA 94143, USA., Shear MA; Division of Medical Genetics, Department of Pediatrics, UCSF School of Medicine, San Francisco, CA 94143, USA., Moore AT; UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.; Department of Ophthalmology, UCSF School of Medicine, San Francisco, CA 94143, USA., Duncan JL; Department of Ophthalmology, UCSF School of Medicine, San Francisco, CA 94143, USA., Menendez B; Department of Pediatrics, University of Illinois School of Medicine, Chicago, IL 60612, USA., Hull S; Department of Ophthalmology, University of Auckland, Auckland 1023, New Zealand., Vincent AL; Department of Ophthalmology, University of Auckland, Auckland 1023, New Zealand., Siskind CE; Neurology and Neurological Sciences, Stanford School of Medicine, Stanford, CA 94305, USA., Traboulsi EI; The Center for Genetic Eye Diseases, The Cleveland Clinic Eye Institute, Cleveland, OH 44106, USA., Blackstone C; Movement Disorders Division, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA., Sisk RA; Department of Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA., Miraldi Utz V; Department of Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.; Abrahamson Pediatric Eye Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA., Webster AR; UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.; Department of Genetics, Moorfields Eye Hospital NHS Trust, London EC1V 2PD, UK., Michaelides M; UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.; Department of Genetics, Moorfields Eye Hospital NHS Trust, London EC1V 2PD, UK., Arno G; UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.; Department of Genetics, Moorfields Eye Hospital NHS Trust, London EC1V 2PD, UK., Synofzik M; Division Translational Genomics of Neurodegenerative Diseases Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany., Hufnagel RB; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Department of Genetics and Center for Integrated Healthcare Research, Kaiser Permanente Hawaii Region, Honolulu, HI 98619, USA.

Publikováno v: Brain : a journal of neurology [Brain] 2024 Jun 03; Vol. 147 (6), pp. 2085-2097.

Commissioning of Aktina SRS cones and dosimetric validation of the RayStation photon Monte Carlo dose calculation algorithm.

Autor: Schofield A; Radiation Oncology Department, Prince of Wales Hospital, Randwick, NSW, 2031, Australia., Newall M; Radiation Oncology Department, Prince of Wales Hospital, Randwick, NSW, 2031, Australia., Inwood D; Radiation Oncology Department, Prince of Wales Hospital, Randwick, NSW, 2031, Australia., Downes S; Radiation Oncology Department, Prince of Wales Hospital, Randwick, NSW, 2031, Australia., Corde S; Radiation Oncology Department, Prince of Wales Hospital, Randwick, NSW, 2031, Australia. scorde@uow.edu.au.; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, 2522, Australia. scorde@uow.edu.au.; Illawara Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, 2522, Australia. scorde@uow.edu.au.

Publikováno v: Physical and engineering sciences in medicine [Phys Eng Sci Med] 2023 Dec; Vol. 46 (4), pp. 1503-1518. Date of Electronic Publication: 2023 Aug 21.

Drop-off behaviour of Bt-resistant and Bt-susceptible Helicoverpa armigera (Hübner) (Lepidoptera: Noctuidae) larvae on Bt-cotton and non-Bt cotton plants.

Autor: Luong, T. T. A., Downes, S. J., Perkins, L. E., Zalucki, M. P.

Publikováno v: Bulletin of Entomological Research; Oct2022, Vol. 112 Issue 5, p604-612, 9p